149 related articles for article (PubMed ID: 27589051)
1. Two-year patient-reported outcomes following treatment of uveal melanoma.
Hope-Stone L; Brown SL; Heimann H; Damato B; Salmon P
Eye (Lond); 2016 Dec; 30(12):1598-1605. PubMed ID: 27589051
[TBL] [Abstract][Full Text] [Related]
2. Phantom Eye Syndrome: Patient Experiences after Enucleation for Uveal Melanoma.
Hope-Stone L; Brown SL; Heimann H; Damato B; Salmon P
Ophthalmology; 2015 Aug; 122(8):1585-90. PubMed ID: 26004080
[TBL] [Abstract][Full Text] [Related]
3. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study.
Brandberg Y; Kock E; Oskar K; af Trampe E; Seregard S
Eye (Lond); 2000 Dec; 14(Pt 6):839-46. PubMed ID: 11584839
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.
Klingenstein A; Fürweger C; Mühlhofer AK; Leicht SF; Schaller UC; Muacevic A; Wowra B; Hintschich C; Eibl KH
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1005-12. PubMed ID: 26573389
[TBL] [Abstract][Full Text] [Related]
5. Depression, Anxiety, and Regret Before and After Testing to Estimate Uveal Melanoma Prognosis.
Schuermeyer I; Maican A; Sharp R; Bena J; Triozzi PL; Singh AD
JAMA Ophthalmol; 2016 Jan; 134(1):51-6. PubMed ID: 26539659
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial impact of prognostic genetic testing in the care of uveal melanoma patients: protocol of a controlled prospective clinical observational study.
Erim Y; Scheel J; Breidenstein A; Metz CH; Lohmann D; Friederich HC; Tagay S
BMC Cancer; 2016 Jul; 16():408. PubMed ID: 27386847
[TBL] [Abstract][Full Text] [Related]
7. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
van Beek JGM; Buitendijk GHS; Timman R; Muller K; Luyten GPM; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2018 Dec; 96(8):841-848. PubMed ID: 30284368
[TBL] [Abstract][Full Text] [Related]
8. Depression and quality of life during treatment of ocular bulb removal in individuals with uveal melanoma.
Amaro TA; Yazigi L; Erwenne C
Eur J Cancer Care (Engl); 2010 Jul; 19(4):476-81. PubMed ID: 19912303
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial impact of prognostic genetic testing in uveal melanoma patients: a controlled prospective clinical observational study.
Lieb M; Tagay S; Breidenstein A; Hepp T; Le Guin CHD; Scheel J; Lohmann DR; Bornfeld N; Teufel M; Erim Y
BMC Psychol; 2020 Jan; 8(1):8. PubMed ID: 32005293
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in the follow-up of uveal melanoma patients after CyberKnife treatment.
Klingenstein A; Fürweger C; Nentwich MM; Schaller UC; Foerster PI; Wowra B; Muacevic A; Eibl KH
Melanoma Res; 2013 Dec; 23(6):481-8. PubMed ID: 24048223
[TBL] [Abstract][Full Text] [Related]
11. Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research.
Cook SA; Damato B; Marshall E; Salmon P
Eye (Lond); 2009 Mar; 23(3):581-5. PubMed ID: 18344957
[TBL] [Abstract][Full Text] [Related]
12. [Psychological aspects and quality of life in uveal melanoma patients during the treatment process by ocular bulb remotion].
Amaro TA; Yazigi L; Erwenne C
Arq Bras Oftalmol; 2006; 69(6):889-94. PubMed ID: 17273685
[TBL] [Abstract][Full Text] [Related]
13. Long-term uveal melanoma survivors: measuring their quality of life.
Frenkel S; Rosenne H; Briscoe D; Hendler K; Bereket R; Molcho M; Pe'er J
Acta Ophthalmol; 2018 Jun; 96(4):e421-e426. PubMed ID: 29369538
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma.
Gollrad J; Rabsahl C; Riechardt AI; Heufelder J; Stroux A; Goerling U; Joussen A; Budach V; Boehmer D
Radiat Oncol; 2021 Sep; 16(1):174. PubMed ID: 34496895
[TBL] [Abstract][Full Text] [Related]
15. Translation and validation of the Polish version of the EORTC QLQ-OPT30 module for the assessment of health-related quality of life in patients with uveal melanoma.
Chmielowska K; Tomaszewski KA; Pogrzebielski A; Brandberg Y; Romanowska-Dixon B
Eur J Cancer Care (Engl); 2013 Jan; 22(1):88-96. PubMed ID: 22966840
[TBL] [Abstract][Full Text] [Related]
16. Sociodemographic, Medical, and Psychosocial Factors Associated With Supportive Care Needs in Adults Diagnosed With Uveal Melanoma.
Williamson TJ; Jorge-Miller A; McCannel TA; Beran TM; Stanton AL
JAMA Ophthalmol; 2018 Apr; 136(4):356-363. PubMed ID: 29470565
[TBL] [Abstract][Full Text] [Related]
17. The use of semistructured interviews to assess quality of life impacts for patients with uveal melanoma.
Kopp BC; Crump RT; Weis E
Can J Ophthalmol; 2017 Apr; 52(2):181-185. PubMed ID: 28457288
[TBL] [Abstract][Full Text] [Related]
18. Prediction of all-cause mortality from 24 month trajectories in patient-reported psychological, clinical and quality of life outcomes in uveal melanoma patients.
Brown SL; Fisher PL; Hope-Stone L; Heimann H; Hussain R; Cherry MG
J Behav Med; 2022 Feb; 45(1):115-123. PubMed ID: 34453274
[TBL] [Abstract][Full Text] [Related]
19. The national comprehensive cancer network distress thermometer as a screening tool for the evaluation of quality of life in uveal melanoma patients.
Klingenstein A; Samel C; Garip-Kuebler A; Miller C; Liegl RG; Priglinger SG; Foerster PI
Acta Ophthalmol; 2020 May; 98(3):e381-e387. PubMed ID: 31654488
[TBL] [Abstract][Full Text] [Related]
20. Predictors of anxiety and depression 2 years following treatment in uveal melanoma survivors.
Brown SL; Hope-Stone L; Heimann H; Damato B; Salmon P
Psychooncology; 2018 Jul; 27(7):1727-1734. PubMed ID: 29601654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
